Bio-Techne
TECH
£46.75
Share price
0.45%
Change (1 day)
-14.89%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) Fails to deliver data
Key failure to deliver metrics for Bio-Techne:
- Last SEC data release: 2025-02-28
- Last 15 days FTD volume: £0.08 M
- Last 3 months FTD volume: £0.28 M
- Last year FTD volume: £0.28 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Bio-Techne (TECH) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Bio-Techne (TECH) - since 2014
Volume in USD (price x number of shares), data since 2014Bio-Techne (TECH) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | £0.09 M | -99.68% |
| 2024 | £29 M | -32.17% |
| 2023 | £42.76 M | -15.62% |
| 2022 | £50.68 M | -42.56% |
| 2021 | £88.22 M | 200.19% |
| 2020 | £29.39 M | 124.27% |
| 2019 | £13.1 M | 90.7% |
| 2018 | £6.87 M | -5.05% |
| 2017 | £7.23 M | -54.94% |
| 2016 | £16.06 M | 17.78% |
| 2015 | £13.63 M | 342.13% |
| 2014 | £3.08 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | £18.62 M | £0.17 B | 🇺🇸 USA |
 | £2.81 M | £14.44 M | 🇺🇸 USA |
 | £14.79 M | £76.13 M | 🇺🇸 USA |
 | £17.11 M | £0.21 B | 🇺🇸 USA |
 | £2.22 M | £2.22 M | 🇳🇱 Netherlands |
 | £0.27 B | £1.43 B | 🇺🇸 USA |
 | £0.1 M | £0.14 M | 🇺🇸 USA |